NCT06819202View on ClinicalTrials.gov

Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function

Not yet recruitingOBSERVATIONAL
Enrollment

1,309

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2025

Conditions
Sudden Sensorineural Hearing Loss (SSNHL)Hyperbaric Oxygen Therapy
Interventions
OTHER

Hyperbaric oxygen treatment

HBO therapy is the process of inhaling 100% pure oxygen in an environment above one atmosphere (pressure range: 2.0-3.0 absolute atmospheres) to treat a disease.

Trial Locations (1)

200333

Shanghai University of Traditional Chinese Medicine, Shanghai

All Listed Sponsors
lead

Sun Yuting

OTHER

NCT06819202 - Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function | Biotech Hunter | Biotech Hunter